These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7406481)

  • 41. Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin.
    Hartstein AI; Patrick KE; Jones SR; Miller MJ; Bryant RE
    Antimicrob Agents Chemother; 1977 Jul; 12(1):93-7. PubMed ID: 883822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux.
    Pomeranz A; El-Khayam A; Korzets Z; Kessler OJ; Godfrey L; Katz B; Wolach B
    J Urol; 2000 Sep; 164(3 Pt 2):1070-3. PubMed ID: 10958743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability of new galenic preparations of cephalexin (author's transl)].
    Guggenbichler JP; Kienel G
    Padiatr Padol; 1978; 13(3):315-20. PubMed ID: 673437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Pinget M; Dorner M; Lavillaureix J
    J Clin Pharmacol; 1975 Oct; 15(10):666-73. PubMed ID: 1184770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats.
    Berlioz F; Lepére-Prevot B; Julien S; Tsocas A; Carbon C; Rozé C; Farinotti R
    Drug Metab Dispos; 2000 Nov; 28(11):1267-9. PubMed ID: 11038150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacology of cefaclor and cephalexin.
    Korzeniowski OM; Scheld WM; Sande MA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):157-62. PubMed ID: 900915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic profile of nicorandil in humans: an overview.
    Frydman A
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S34-44. PubMed ID: 1282174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.
    Lode H; Stahlmann R; Koeppe P
    Antimicrob Agents Chemother; 1979 Jul; 16(1):1-6. PubMed ID: 475366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of cefadroxil after oral administration in humans.
    La Rosa F; Ripa S; Prenna M; Ghezzi A; Pfeffer M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):320-2. PubMed ID: 7073267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The fractional inhibitory concentration (FIC) index as a measure of synergy.
    Hall MJ; Middleton RF; Westmacott D
    J Antimicrob Chemother; 1983 May; 11(5):427-33. PubMed ID: 6874629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of the kinetics of cephapirin and cephalexin in pregnancy.
    Creatsas G; Pavlatos M; Lolis D; Kaskarelis D
    Curr Med Res Opin; 1980; 7(1):43-6. PubMed ID: 7428412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose.
    Garrett ER; Jackson AJ
    J Pharm Sci; 1979 Jun; 68(6):753-71. PubMed ID: 458581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I study of multiple-dose cefprozil and comparison with cefaclor.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Martin RR; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1198-203. PubMed ID: 2393281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transport mechanism of cephalexin in isolated hepatocytes.
    Tamai I; Tsuji A
    J Pharmacobiodyn; 1987 Nov; 10(11):632-8. PubMed ID: 3446770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.